Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Brexit’s impact on UK life sciences: some key points
  2. Lilly teams up with AC Immune for Alzheimer’s drug
  3. GARDP, Eisai and Takeda join forces to identify new antibiotics
  4. Future NASH reimbursement issues may echo HCV therapies
  5. Is China the next great hope for the pharma industry?

Latest Content

Pharmaceutical Challenges Aided by Laboratory Powder X-ray Diffraction

This white paper explores a number of ways that today's modern, laboratory-based powder x-ray diffraction (PXRD) instrumentation and advanced software can greatly assist pharmaceutical scientists in their quest to develop high-quality, stable products and accelerate their speed-to-market.

Trehalose: A Powerful Excipient in the Formulation Toolbox

In the pharmaceutical industry, products that benefit from the stabilising effects of trehalose include, but are not limited to, monoclonal antibodies (mAbs), antibody drug conjugates (ADCs), fusion proteins, peptides, stem cells and vaccines.

Lilly teams up with AC Immune for Alzheimer’s drug

Eli Lilly has signed a licence and collaboration agreement with Swiss biotech AC Immune for the research and development of tau aggregation inhibitor small molecules to treat neurodegenerative disorders, including Alzheimer’s disease.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top